Related Experiment Video
Updated: Feb 14, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Klebsiella oxytoca: an opportunistic bacterial pathogen that poses challenges for treatment and vaccine development
Gabriela Guerrera Soares1, Maria Carolina Francalassi Sarcinelli1, Marcelo Silva Folhas Damas1,2
1Departamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, Brazil.
Abstract:
Klebsiella oxytoca is a clinically significant opportunistic bacterium that contributes to global morbidity and mortality. Despite its clinical relevance, the genomic diversity, virulence factors, and immune evasion mechanisms of this pathogen are not yet fully elucidated. This review provides an overview of current knowledge on antibiotic resistance in K. oxytoca, a characteristic that poses a significant challenge to therapeutic options. We discuss available bacterial vaccines and their role in mitigating antimicrobial resistance, reducing infection rates, and lowering antibiotic use. We also examine the challenges of developing a vaccine against K. oxytoca using traditional approaches, including reliance on animal testing, high production costs, and the lengthy timelines associated with vaccine development. We also suggest that emerging tools such as subtractive proteomics, reverse vaccinology, artificial intelligence, and machine learning offer promising effects to accelerate the identification of vaccine candidates against this pathogen even though few studies have applied these tools specifically to K. oxytoca. Overall, despite progress in understanding K. oxytoca, further research is needed to develop innovative therapeutic and preventive strategies, including effective vaccines.
Insights
Klebsiella oxytoca is a major cause of illness and death. This review explores antibiotic resistance, vaccine development challenges, and new tools like AI for creating effective Klebsiella oxytoca vaccines.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Klebsiella oxytoca is a significant opportunistic pathogen contributing to global morbidity and mortality.
- Limited understanding of its genomic diversity, virulence factors, and immune evasion mechanisms hinders effective control.
- Antibiotic resistance in K. oxytoca presents a major therapeutic challenge.
Purpose of the Study:
- To review current knowledge on antibiotic resistance in K. oxytoca.
- To discuss the potential of bacterial vaccines in mitigating antimicrobial resistance and infection rates.
- To examine challenges in traditional vaccine development and explore novel approaches.
Main Methods:
- Literature review of K. oxytoca research.
- Analysis of antibiotic resistance patterns.
- Evaluation of traditional and emerging vaccine development strategies.
- Exploration of subtractive proteomics, reverse vaccinology, AI, and machine learning.
Main Results:
- K. oxytoca exhibits significant antibiotic resistance, complicating treatment.
- Traditional vaccine development faces hurdles like animal testing, high costs, and long timelines.
- Emerging technologies show promise for accelerating vaccine candidate identification.
Conclusions:
- Further research is essential to overcome K. oxytoca's challenges.
- Innovative therapeutic and preventive strategies, particularly effective vaccines, are urgently needed.
- Novel approaches like AI and machine learning could revolutionize vaccine development for K. oxytoca.
Related Concept Videos
Vaccinations
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Sustainable Development
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Signaling

